Editorial: Women in thyroid endocrinology 2022 by Laura Sterian Ward, Clara Ugolini, Rossella Elisei

Get full text

Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer by Eleonora Molinaro, David Viola, Nicola Viola, Pierpaolo Falcetta, Francesca Orsolini, Liborio Torregrossa, Paola Vagli, Alessandro Ribechini, Gabriele Materazzi, Paolo Vitti, Rossella Elisei

Get full text

Molecular predictive biomarker testing in advanced thyroid cancer – a European consensus by Aleš Ryška, Jaume Capdevila, Matthias S Dettmer, Rossella Elisei, Dagmar Führer, Julien Hadoux, Barbara Jarząb, Laura D Locati, Kate Newbold, Giovanni Tallini, Silvia Uccella, Lori Wirth, Ravinder Singh, Iris M Simon, Pilar Camacho, Laura Fugazzola

Get full text

Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study) by Giulia Puliani, Marta Bianchini, Carlotta Giani, Laura Valerio, Alice Nervo, Giulia Sapuppo, Giorgio Grani, Cristina Dalmiglio, Simone De Leo, Rosa Lauretta, Marilda Mormando, Irene Terrenato, Stefania Zovato, Laura Fugazzola, Maria Grazia Castagna, Cosimo Durante, Gabriella Pellegriti, Emanuela Arvat, Rossella Elisei, Marialuisa Appetecchia

Get full text